| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12. | Integrum AB: Integrum's rights issue oversubscribed | 81 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing... ► Artikel lesen | |
| INTEGRUM Aktie jetzt für 0€ handeln | |||||
| 21.11. | Integrum AB Q2 Loss Narrows | 1 | RTTNews | ||
| 21.11. | Integrum AB: Integrum publishes Interim Report for Q2 2025/26 | 100 | GlobeNewswire (Europe) | Second Quarter 2025/26 (August - October)
Net sales amounted to SEK 22.3 (21.8) million.
Operating result totalled SEK -11.1 (-11.3) million.
Profit/loss after tax amounted to SEK -7.4 (-8.9)... ► Artikel lesen | |
| 19.11. | Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation | 1 | Cision News | ||
| 19.11. | True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren | 244 | Business Wire | True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft... ► Artikel lesen | |
| 18.11. | INTEGRUM AB: The subscription period in Integrum's rights issue has begun | 1 | Cision News | ||
| 13.11. | Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26 | 141 | GlobeNewswire (Europe) | Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures... ► Artikel lesen | |
| 11.11. | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025 | 289 | Xetra Newsboard | Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das... ► Artikel lesen | |
| 10.11. | Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs | 121 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term... ► Artikel lesen | |
| 23.10. | Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus | 161 | GlobeNewswire (Europe) | Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA... ► Artikel lesen | |
| 20.10. | Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum | 159 | GlobeNewswire (Europe) | Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)... ► Artikel lesen | |
| 16.10. | Integrum: $2.5 Billion Fund II Closed, Bringing Total Assets To $5 Billion | 2 | pulse2.com | ||
| 16.10. | Integrum AB: Integrum provides operational update ahead of Q2 report | 100 | GlobeNewswire (Europe) | Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking... ► Artikel lesen | |
| 16.10. | Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report | 194 | GlobeNewswire (Europe) | The Board of Directors of Integrum AB (publ) ("Integrum" or the "Company") has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential... ► Artikel lesen | |
| 01.10. | Duke Capital - Follow-On Investment into Integrum Group Holdings | 4 | RNS | ||
| 25.09. | The observation status for Integrum AB is removed | 188 | GlobeNewswire | On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a... ► Artikel lesen | |
| 18.09. | INTEGRUM AB: Integrum provides update on OsteoCentric's public offer and provides correction of previous announced information | 4 | Cision News | ||
| 17.09. | INTEGRUM AB: Integrum comments on OsteoCentric's announcement of outcome in the public offer | 1 | Cision News | ||
| 16.09. | OSTEOCENTRIC ONCOLOGY AND BONE ANCHORED PROSTHESES LLC: FINAL OUTCOME FOR THEIC OFFER BY OSTEOCENTRIC TO THE SHAREHOLDERS OF INTEGRUM: OSTEOCENTRIC DOES NOT COMPLETE THE OFFER | 3 | Cision News | ||
| 04.09. | INTEGRUM AB: Integrum Unveils Global Marketing Strategy at AOPA National Assembly | 1 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 83,59 | +0,52 % | Medtronic: Will a Robot Help Perform Your Next Surgery? | FDA clears the Medtronic Hugo robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / December 15, 2025 / James Choate-Deeds and his wife Caryn held hands and braced... ► Artikel lesen | |
| INTUITIVE SURGICAL | 473,00 | +0,20 % | Intuitive Surgical, Inc.: Intuitive Announces Expanded Indications for da Vinci SP | SUNNYVALE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that... ► Artikel lesen | |
| THERMO FISHER | 481,65 | -0,76 % | Thermo Fisher Scientific - TMO: Analysten & Großinvestoren sind bullisch gestimmt! | Breakout-Setup! Kursziele bis 750 USD! Thermo Fisher Scientific (TMO) stärkt seine Präsenz in Asien! Thermo Fisher Scientific (TMO) - ISIN US8835561023 Rückblick: Mit einem Kursplus von 42 Prozent und... ► Artikel lesen | |
| STRATEC | 22,000 | -0,68 % | ROUNDUP/Aktien Frankfurt Schluss: Im Plus - Starke Autowerte und US-Zinshoffnung | FRANKFURT (dpa-AFX) - Der Optimismus über wohl weiter sinkende Zinsen in den USA hat am Donnerstag den deutschen Aktienmarkt angetrieben. Hinzu kam eine starke Autobranche, die dem Dax Auftrieb gab.... ► Artikel lesen | |
| HIMS & HERS HEALTH | 30,050 | -4,24 % | Hims & Hers Health, Inc: Hims & Hers Brings Comprehensive Weight Loss Programme to the UK | Expansion Debuts Hers, Unlocking Personalised Care for British WomenLONDON, Dec. 10, 2025 /PRNewswire/ -- Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 59,14 | +1,51 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| BECTON DICKINSON | 166,50 | -0,39 % | BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe | ||
| FAMICORD | 6,250 | -2,34 % | FAMICORD AG zündet turbo - ich sehe den Wendepunkt jetzt! | ||
| GERATHERM MEDICAL | 3,030 | -3,81 % | GERATHERM MEDICAL AG: Jetzt entscheidet sich alles! | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 81,00 | +2,27 % | UBS bestätigt Kaufempfehlung für Boston Scientific mit Kursziel von 140 US-Dollar | ||
| PAUL HARTMANN | 225,00 | 0,00 % | Januar bis September 2025: PAUL HARTMANN steigert Umsatz trotz schwächerer Absatzmärkte | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.826,0 Mio. EUR, organisches Umsatzwachstum von 2,0 % - Bereinigtes EBITDA liegt bei 195,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,7 % - Unternehmen... ► Artikel lesen | |
| RESMED | 210,40 | -0,10 % | Tandem Diabetes upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 | ||
| MCKESSON | 682,00 | -1,07 % | If You Invested $100 In McKesson Stock 20 Years Ago, You Would Have This Much Today | ||
| INMODE | 12,305 | -0,28 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |